Ability of Matrix Metalloproteinase-8 Biosensor, IFMA, and ELISA Immunoassays to Differentiate Between Periodontal Health, Gingivitis, and Periodontitis
Overview
Authors
Affiliations
Objective: The aim of this study was to determine the diagnostic utility of an MMP-8 biosensor assay in differentiating periodontal health from gingivitis and periodontitis and compare it with an established time-resolved immunofluorescence assay (IFMA) and enzyme-linked immunosorbent assay (ELISA).
Background: Currently available antibody-based assays display a wide variability in their ability to accurately measure matrix metalloproteinase-8 (MMP-8) levels in saliva.
Methods: Salivary MMP-8 levels were analyzed in 189 systemically healthy participants using an antibody-based biosensor prototype that operates using a surface acoustic wave technology and compared with IFMA and ELISA antibody assays. Participants were categorized into 3 groups: periodontal health (59), gingivitis (63), and periodontitis (67). A sub-population of participants (n = 20) with periodontitis received periodontal treatment and were monitored for 6 months.
Results: All the assays demonstrated significantly higher salivary MMP-8 concentrations in participants with periodontitis versus gingivitis, periodontitis versus health, and gingivitis versus health (all p < .05). The biosensor data demonstrated significant correlations with IFMA (r = .354, p < .001) and ELISA (r = .681, p < .001). Significant reductions in salivary MMP-8 concentrations were detected by the biosensor (p = .030) and IFMA (p = .002) in participants with periodontitis 6 months after non-surgical periodontal treatment. IFMA had the best sensitivity (89.2%) for detecting periodontitis and gingivitis versus health and 96.6% for detecting periodontitis versus health and gingivitis. The biosensor had an AUC value of 0.81 and diagnostic accuracy of 74.2% for differentiating periodontitis and gingivitis from health; an AUC value of 0.86 and diagnostic accuracy of 82.8% for periodontitis versus health and gingivitis.
Conclusions: The biosensor, IFMA, and ELISA assays differentiated between periodontal health, gingivitis, and periodontitis based on salivary MMP-8 levels. Only the biosensor and, particularly, IFMA identified an effect of periodontal treatment in the participants with periodontitis. Our findings support the potential utility of salivary oral fluid aMMP-8-based point-of-care technology in the future of periodontal diagnostics.
Boynes S, Sofiyeva N, Saw T, Nieto V, Palomo L Front Oral Health. 2025; 6:1444399.
PMID: 40045958 PMC: 11880025. DOI: 10.3389/froh.2025.1444399.
Domokos Z, Simon F, Uhrin E, Szabo B, Vancsa S, Varga G Heliyon. 2024; 10(22):e40402.
PMID: 39641024 PMC: 11617734. DOI: 10.1016/j.heliyon.2024.e40402.
Point-of-care diagnostic devices for periodontitis - current trends and urgent need.
Griffith A, Chande C, Kulkarni S, Morel J, Cheng Y, Shimizu E Sens Diagn. 2024; 3(7):1119-1134.
PMID: 39007012 PMC: 11238172. DOI: 10.1039/d3sd00317e.
Baima G, Romano F, Franco F, Roato I, Mussano F, Berta G Int J Mol Sci. 2024; 25(12).
PMID: 38928390 PMC: 11204308. DOI: 10.3390/ijms25126687.
Exploring the Efficacy of Novel Therapeutic Strategies for Periodontitis: A Literature Review.
Radu C, Radu C, Arbanasi E, Hogea T, Murvai V, Chis I Life (Basel). 2024; 14(4).
PMID: 38672739 PMC: 11050937. DOI: 10.3390/life14040468.